KORE Adjusted EBITDA Increases to $15.4M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 11 2026
0mins
Adjusted EBITDA increased to $15.4M, up $1M or 7% from the same period last year. "The first quarter of 2026 demonstrates the momentum in our core IoT Connectivity business, which continues to be the engine of our growth. Adding over two million connections year-over-year while increasing our IoT Connectivity revenue is a testament to the essential role we play for our customers," said Ron Totton, KORE's President & CEO. "This focus on our core services allowed us to once again deliver positive free cash flow for our stockholders," added Totton.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KORE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KORE
Wall Street analysts forecast KORE stock price to fall
2 Analyst Rating
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 9.190
Low
5.00
Averages
5.00
High
5.00
Current: 9.190
Low
5.00
Averages
5.00
High
5.00
About KORE
KORE Group Holdings, Inc. is a global pure-play Internet of Things (IoT) hyperscaler and provider of IoT connectivity, solutions, and analytics. The Company is a global independent IoT enabler, delivering critical services globally to customers to deploy, manage, and scale their IoT application and use cases. It provides advanced connectivity services, location-based services, device solutions, and managed and professional services used in the development and support of IoT solutions and applications. It provides connectivity and IoT solutions to enterprise customers across five industry verticals, comprising of connected health, fleet management, asset monitoring, retail communications services and industrial IoT. The Company has built a platform to serve its clients in three areas: connectivity-as-a-service (CaaS), IoT managed services/solutions, and analytics, which the Company refers to as CSA, or connectivity, solutions, and analytics.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating companies such as KORE Group Holdings, Inc., Select Medical Holdings Corporation, and TopBuild Corp. for potential violations of federal securities laws or breaches of fiduciary duties, which may impact shareholder rights.
- KORE Transaction Details: KORE Group Holdings, Inc. is being sold to Searchlight Capital Partners, L.P. and Abry Partners for $9.25 per share, with terms that may limit superior competing offers, affecting shareholder options.
- Select Medical Sale: Select Medical Holdings Corporation is being sold for $16.50 per share to a consortium led by company executives and directors, and Halper Sadeh LLC may seek increased compensation for shareholders.
- TopBuild Shareholder Options: TopBuild Corp. shareholders can choose to sell their shares for $505.00 in cash or 20.2 shares of QXO common stock, with Halper Sadeh LLC representing shareholders to seek additional disclosures and rights protection.
See More
KORE Group Holdings Q1 Financial Results Analysis
- Increased Net Loss: KORE Group Holdings reported a net loss of $28.5 million in Q1, which is an increase of $13.5 million or 91% year-over-year, primarily due to transaction-related expenses and changes in the fair value of warrant liabilities, indicating challenges in cost management.
- Revenue Decline: The company’s revenue for the first quarter was $65.82 million, reflecting an 8.8% year-over-year decline and missing expectations by $6.38 million, which highlights pressures from weak market demand and intensified competition.
- Adjusted EBITDA Growth: Despite the losses, KORE's adjusted EBITDA rose to $15.4 million, up $1.0 million or 7% from the previous year, suggesting improvements in operational efficiency amidst challenging conditions.
- Free Cash Flow Improvement: Free cash flow increased to $2.7 million, a rise of $2.1 million year-over-year, demonstrating positive progress in cash flow management that supports future investments and operational stability.
See More
KORE Group Reports Growth in Free Cash Flow for Q1 2026
- Connection Growth: KORE Group added over 2 million connections in Q1 2026, reaching a total of 21.9 million, demonstrating robust growth in its core IoT connectivity business and reinforcing its market leadership.
- Revenue Performance: The IoT connectivity revenue for the first quarter was $56.212 million, accounting for 85% of total revenue, despite total revenue declining to $65.819 million from $72.142 million in Q1 2025, reflecting the company's continued focus on core services.
- Free Cash Flow Improvement: KORE achieved free cash flow of $2.743 million in Q1, a significant increase from $597,000 in the same period of 2025, indicating enhanced operational efficiency and capital management that supports future investments and debt repayments.
- Merger Transaction Progress: KORE has entered into a merger agreement with KONA Parent, L.P., expected to close in Q2 or Q3 2026, with an enterprise value of approximately $726 million, marking a transition to a private company that may influence its future strategic direction.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating companies like Select Medical Holdings, XOMA Royalty Corporation, Soleno Therapeutics, and KORE Group Holdings for potential violations of federal securities laws and fiduciary duties, which may impact shareholder rights.
- Select Medical Transaction: Shareholders of Select Medical may face a sale to a consortium led by executives at $16.50 per share, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures to protect shareholder interests.
- XOMA Royalty Transaction: XOMA Royalty Corporation shareholders are set to sell to Ligand Pharmaceuticals for $39.00 per share, and Halper Sadeh LLC may advocate for higher transaction prices and transparency to ensure shareholders' legal rights are upheld.
- Soleno and KORE Transactions: Soleno Therapeutics shareholders will sell to Neurocrine Biosciences for $53.00 per share, while KORE Group Holdings shareholders will sell to Searchlight Capital Partners and Abry Partners for $9.25 per share, with Halper Sadeh LLC providing legal support to ensure these shareholders' rights are protected.
See More
Investigation Launched into KORE Group Merger Deal
- Board Investigation: Levi & Korsinsky, LLP has initiated an investigation into potential breaches of fiduciary duty by KORE Group's Board of Directors regarding the all-cash merger agreement with Searchlight Capital Partners and Abry Partners, raising concerns about shareholder rights.
- Acquisition Terms: Under the merger agreement, KORE shareholders are expected to receive $9.25 per share in cash, a price that may influence shareholder acceptance of the deal and their future investment decisions.
- Legal Advisory Services: Levi & Korsinsky offers no-cost legal consultations to assist KORE shareholders in understanding their rights and assessing whether the Board's decisions align with shareholder interests, potentially impacting shareholder trust in the company.
- Reputation Risk: This investigation could negatively affect KORE Group's market reputation, especially if shareholder trust in the Board declines, potentially leading to shareholder attrition and stock price volatility.
See More
Investigation Launched into KORE Group's Merger Agreement
- Merger Agreement Investigation: Levi & Korsinsky, LLP has initiated an investigation into potential breaches of fiduciary duty by KORE Group's Board of Directors regarding a definitive merger agreement with Searchlight Capital Partners and Abry Partners, where shareholders are expected to receive $9.25 per share in cash.
- Shareholder Rights Concern: The investigation focuses on whether the Board violated its fiduciary duties to shareholders, which could impact shareholder confidence in the merger agreement and future investment decisions.
- Legal Expertise: Levi & Korsinsky is a nationally recognized firm with extensive experience in securities litigation, having recovered hundreds of millions of dollars for investors, demonstrating its strong capability in protecting shareholder rights.
- No Cost Participation: Shareholders can learn more and participate in the investigation at no cost by visiting the designated website or contacting the attorney, providing an opportunity for shareholders to safeguard their interests.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating companies such as KORE Group Holdings, Inc., Select Medical Holdings Corporation, and TopBuild Corp. for potential violations of federal securities laws or breaches of fiduciary duties, which may impact shareholder rights.
- KORE Transaction Details: KORE Group Holdings, Inc. is being sold to Searchlight Capital Partners, L.P. and Abry Partners for $9.25 per share, with terms that may limit superior competing offers, affecting shareholder options.
- Select Medical Sale: Select Medical Holdings Corporation is being sold for $16.50 per share to a consortium led by company executives and directors, and Halper Sadeh LLC may seek increased compensation for shareholders.
- TopBuild Shareholder Options: TopBuild Corp. shareholders can choose to sell their shares for $505.00 in cash or 20.2 shares of QXO common stock, with Halper Sadeh LLC representing shareholders to seek additional disclosures and rights protection.
See More
KORE Group Holdings Q1 Financial Results Analysis
- Increased Net Loss: KORE Group Holdings reported a net loss of $28.5 million in Q1, which is an increase of $13.5 million or 91% year-over-year, primarily due to transaction-related expenses and changes in the fair value of warrant liabilities, indicating challenges in cost management.
- Revenue Decline: The company’s revenue for the first quarter was $65.82 million, reflecting an 8.8% year-over-year decline and missing expectations by $6.38 million, which highlights pressures from weak market demand and intensified competition.
- Adjusted EBITDA Growth: Despite the losses, KORE's adjusted EBITDA rose to $15.4 million, up $1.0 million or 7% from the previous year, suggesting improvements in operational efficiency amidst challenging conditions.
- Free Cash Flow Improvement: Free cash flow increased to $2.7 million, a rise of $2.1 million year-over-year, demonstrating positive progress in cash flow management that supports future investments and operational stability.
See More
KORE Group Reports Growth in Free Cash Flow for Q1 2026
- Connection Growth: KORE Group added over 2 million connections in Q1 2026, reaching a total of 21.9 million, demonstrating robust growth in its core IoT connectivity business and reinforcing its market leadership.
- Revenue Performance: The IoT connectivity revenue for the first quarter was $56.212 million, accounting for 85% of total revenue, despite total revenue declining to $65.819 million from $72.142 million in Q1 2025, reflecting the company's continued focus on core services.
- Free Cash Flow Improvement: KORE achieved free cash flow of $2.743 million in Q1, a significant increase from $597,000 in the same period of 2025, indicating enhanced operational efficiency and capital management that supports future investments and debt repayments.
- Merger Transaction Progress: KORE has entered into a merger agreement with KONA Parent, L.P., expected to close in Q2 or Q3 2026, with an enterprise value of approximately $726 million, marking a transition to a private company that may influence its future strategic direction.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating companies like Select Medical Holdings, XOMA Royalty Corporation, Soleno Therapeutics, and KORE Group Holdings for potential violations of federal securities laws and fiduciary duties, which may impact shareholder rights.
- Select Medical Transaction: Shareholders of Select Medical may face a sale to a consortium led by executives at $16.50 per share, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures to protect shareholder interests.
- XOMA Royalty Transaction: XOMA Royalty Corporation shareholders are set to sell to Ligand Pharmaceuticals for $39.00 per share, and Halper Sadeh LLC may advocate for higher transaction prices and transparency to ensure shareholders' legal rights are upheld.
- Soleno and KORE Transactions: Soleno Therapeutics shareholders will sell to Neurocrine Biosciences for $53.00 per share, while KORE Group Holdings shareholders will sell to Searchlight Capital Partners and Abry Partners for $9.25 per share, with Halper Sadeh LLC providing legal support to ensure these shareholders' rights are protected.
See More
Investigation Launched into KORE Group Merger Deal
- Board Investigation: Levi & Korsinsky, LLP has initiated an investigation into potential breaches of fiduciary duty by KORE Group's Board of Directors regarding the all-cash merger agreement with Searchlight Capital Partners and Abry Partners, raising concerns about shareholder rights.
- Acquisition Terms: Under the merger agreement, KORE shareholders are expected to receive $9.25 per share in cash, a price that may influence shareholder acceptance of the deal and their future investment decisions.
- Legal Advisory Services: Levi & Korsinsky offers no-cost legal consultations to assist KORE shareholders in understanding their rights and assessing whether the Board's decisions align with shareholder interests, potentially impacting shareholder trust in the company.
- Reputation Risk: This investigation could negatively affect KORE Group's market reputation, especially if shareholder trust in the Board declines, potentially leading to shareholder attrition and stock price volatility.
See More
Investigation Launched into KORE Group's Merger Agreement
- Merger Agreement Investigation: Levi & Korsinsky, LLP has initiated an investigation into potential breaches of fiduciary duty by KORE Group's Board of Directors regarding a definitive merger agreement with Searchlight Capital Partners and Abry Partners, where shareholders are expected to receive $9.25 per share in cash.
- Shareholder Rights Concern: The investigation focuses on whether the Board violated its fiduciary duties to shareholders, which could impact shareholder confidence in the merger agreement and future investment decisions.
- Legal Expertise: Levi & Korsinsky is a nationally recognized firm with extensive experience in securities litigation, having recovered hundreds of millions of dollars for investors, demonstrating its strong capability in protecting shareholder rights.
- No Cost Participation: Shareholders can learn more and participate in the investigation at no cost by visiting the designated website or contacting the attorney, providing an opportunity for shareholders to safeguard their interests.
See More
